In particular, the myofibroblast (Thy1+/Dcn+/Acta2+ (αSMA)) fraction which comprised 4.8% of all cells in the original tumor increased to 15.9% of the tumoroid cells (Figure 8E). This evidence concerns the gene ACTA2 and neoplasm.